Ledger.Open graph →
SEC Form D · filed December 6, 2022

InMed Pharmaceuticals Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Michael C. Woudenberg · Vancouver, British Columbia, CanadaExecCharles King · Murfreesboro, TNDirectorS. S. Singh · Bellevue, WAExec · DirectorEric C. Hsu · Vancouver, British Columbia, CanadaExecJanet J. Grove · Vancouver, British Columbia, CanadaDirectorAngela W. Strange · Cedar Falls, IADirectorNicole J. Lemerond · Vancouver, British Columbia, CanadaDirectorCharles Farguson · New York, NYExecPeter H. Diamandis, Md · Orlando, FLDirectorAndrew J. Hull · Vancouver, British Columbia, CanadaDirectorRobert W. Smith, Jr · Cedar Falls, IAExecJeff S. Drummond · Bellevue, WAExecPetr G. Kilmo · Munsbach, LuxembourgDirectorBryan J. Baldasare · Vancouver, British Columbia, CanadaDirectorAlexandra D. Mancini · Vancouver, British Columbia, CanadaExecYosef A. Quint · Westwood, MAExecCraig M. Hurlbert · Hamilton, MTExecRyan W. Howe · Cedar Falls, IAExec · DirectorWilliam J. Garner · Vancouver, British Columbia, CanadaDirectorEric A. Adams · Vancouver, British Columbia, CanadaExec · DirectorPaul Kirchgraber · Broomfield, CODirectorYuridia V. Rodriguez · Grand Rapids, MIDirectorNicole J. Lemerond · Vancouver, British Columbia, CanadaDirectorUtpal S. Donde · Bellevue, WAExecSarah A. Li · Vancouver, British Columbia, CanadaExecSarah A. Li · Vancouver, British Columbia, CanadaExecMegan H. Pillsbury · Wilmington, DEDirectorKenneth S. Cornick · Bellevue, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗